Key Considerations for GLP-1 Patients GLP-1 receptor agonists like semaglutide and tirzepatide are changing how we approach weight management and metabolic health
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management under the brand name Mounjaro and for chronic weight management as Zepbound
However, the potential immune-balancing effects of BPC-157 definitely make it worth watching
However, while numerous studies indicate that pharmacologic treatment may serve as a first-line option for PDR, it is currently limited to delaying the necessity for PRP [37]
It is not US-approved and using it for autoimmunity is off-label and unproven
At Your Skin Prescription, our skilled aestheticians prioritize your comfort, walking you through every step so you know exactly what to expect in our relaxing and stress-free environment